Particularities of people who inject drugs in a HIV-TB cohort

A. Zaharie (Bucharest, Romania), M. Tigau (Bucharest, Romania)

Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Session: Epidemiological aspects of tuberculosis
Session type: E-poster
Number: 2284

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Zaharie (Bucharest, Romania), M. Tigau (Bucharest, Romania). Particularities of people who inject drugs in a HIV-TB cohort. 2284

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New and repurposed TB drugs use in children and adolescents with M/XDR-TB
Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Year: 2017



Revealing and prophylaxis of a tuberculosis at HIV-infected persons
Source: Eur Respir J 2006; 28: Suppl. 50, 22s
Year: 2006

Active tuberculosis case-finding among drug users and homeless persons: after the outbreak
Source: Eur Respir J 2016; 48: 269-271
Year: 2016


Non-adherence and sub-optimal treatment with asthma medications in young adults: a population-based cohort study
Source: Virtual Congress 2021 – Asthma burden and management I
Year: 2021


Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy
Source: Eur Respir J 2004; 24: 11-17
Year: 2004



Particularities and challenges of TB control in homeless in Romania
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007


Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010


Particularities of tuberculosis at children hospitalized with HIV co-infection
Source: Annual Congress 2009 - Tuberculosis at different age groups
Year: 2009

High prevalence of undiagnosed COPD in a cohort of HIV-infected smokers
Source: Eur Respir J 2015; 45: 828-831
Year: 2015


Immunologic recovery in HIV/TB co-infected patients after anti-TB treatment
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


Effectiveness of treatment for MDR TB in children and adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


A tuberculosis-screening program among HIV-infected patients
Source: Annual Congress 2011 - Tuberculosis epidemiology and public health
Year: 2011

Particularities of tuberculosis in children who contacted persons discharging pathogens in Armenia
Source: Eur Respir J 2005; 26: Suppl. 49, 191s
Year: 2005

Results of TB prophylactics and early detection in HIV-positive people in Moscow, Russia
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018


Antituberculous drug resistance rates in soldier patients newly diagnosed with TB in Turkey
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010

Primary drug resistance of mycobacterium tuberculosis in HIV-positive patients
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Detection of active TB among people living with HIV/AIDS and vulnerable population groups (commercial sex workers and injecting drug users)
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011


HIV-associated disruption of lung cytokine networks is incompletely restored in asymptomatic HIV-infected Malawian adults on antiretroviral therapy
Source: ERJ Open Res, 3 (4) 00097-2017; 10.1183/23120541.00097-2017
Year: 2017



HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015